公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2023 | Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial | Johnston, Stephen R D; Toi, Masakazu; O'Shaughnessy, Joyce; Rastogi, Priya; Campone, Mario; Neven, Patrick; CHIUN-SHENG HUANG ; et al., | The Lancet. Oncology | 136 | 64 | |
2023 | Abemaciclib plus fulvestrant in East Asian women with HR+, HER2- advanced breast cancer: Overall survival from MONARCH 2 | Toi, Masakazu; CHIUN-SHENG HUANG ; Im, Young-Hyuck; Sohn, Joohyuk; Zhang, Wei; Sakaguchi, Sachi; Haddad, Nadine; van Hal, Gertjan; Sledge, George W | Cancer science | 2 | 1 | |
2010 | ACCOMP: Augmented cell competition algorithm for breast lesion demarcation in sonography | Cheng, J.-Z.; Chou, Y.-H.; CHIUN-SHENG HUANG ; YEUN-CHUNG CHANG ; Tiu, C.-M.; Yeh, F.-C.; Chen, K.-W.; Tsou, C.-H.; CHUNG-MING CHEN | Medical Physics | 26 | 22 | |
2008 | Adenoid cystic carcinoma of the breast arising in a lipoma mimicking hamartoma: Imaging manifestations and review of the literature | Kuo P.-H.; CHIUN-SHENG HUANG ; Huang W.-C.; SUNG-HSIN KUO ; JANE WANG | Chinese Journal of Radiology | 2 | | |
2021 | Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study | Harbeck, N; Rastogi, P; Martin, M; Tolaney, S M; Shao, Z M; Fasching, P A; CHIUN-SHENG HUANG ; Jaliffe, G G; Tryakin, A; Goetz, M P; Rugo, H S; Senkus, E; Testa, L; Andersson, M; Tamura, K; Del Mastro, L; Steger, G G; Kreipe, H; Hegg, R; Sohn, J; Guarneri, V; Cortés, J; Hamilton, E; André, V; Wei, R; Barriga, S; Sherwood, S; Forrester, T; Munoz, M; Shahir, A; San Antonio, B; Nabinger, S C; Toi, M; Johnston, S R D; O'Shaughnessy, J | Annals of oncology : official journal of the European Society for Medical Oncology | 206 | 186 | |
2024 | Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes | Rastogi, Priya; O'Shaughnessy, Joyce; Martin, Miguel; Boyle, Frances; Cortes, Javier; Rugo, Hope S; Goetz, Matthew P; Hamilton, Erika P; CHIUN-SHENG HUANG ; et al., | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 3 | | |
2016 | Adjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer: Results From the randomized phase III adjuvant lapatinib and/or trastuzumab treatment optimization trial | Piccart-Gebhart M.; Holmes E.; Baselga J.; De Azambuja E.; Dueck A.C.; Viale G.; Zujewski J.A.; Goldhirsch A.; Armour A.; Pritchard K.I.; McCullough A.E.; Dolci S.; McFadden E.; Holmes A.P.; Tonghua L.; Eidtmann H.; Dinh P.; Di Cosimo S.; Harbeck N.; Tjulandin S.; Im Y.-H.; CHIUN-SHENG HUANG ; Diéras V.; Hillman D.W.; Wolff A.C.; Jackisch C.; Lang I.; Untch M.; Smith I.; Boyle F.; Xu B.; Gomez H.; Suter T.; Gelber R.D.; Perez E.A. | Journal of Clinical Oncology | 308 | 277 | |
2021 | Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE | Mamounas E. P.; Untch M.; Mano M. S.; CHIUN-SHENG HUANG ; Geyer C. E.; von Minckwitz G.; Wolmark N.; Pivot X.; Kuemmel S.; DiGiovanna M.P.; Kaufman B.; Kunz G.; Conlin A.K.; Alcedo J.C.; Kuehn T.; Wapnir I.; Fontana A.; Hackmann J.; Polikoff J.; Saghatchian M.; Brufsky A.; Yang Y.; Zimovjanova M.; Boulet T.; Liu H.; Tesarowski D.; Lam L.H.; Song C.; Smitt M.; Loibl S. | Annals of oncology : official journal of the European Society for Medical Oncology | 62 | 49 | |
2022 | Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE | Loibl, Sibylle; CHIUN-SHENG HUANG ; Mano, Max S; Mamounas, Eleftherios P; Geyer, Charles E; Untch, Michael; et al., | NPJ breast cancer | 15 | 5 | |
2022 | Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trial | Hickish, Tamas; Mehta, Ajay; Liu, Mei-Ching; CHIUN-SHENG HUANG ; Arora, Rajendra Singh; Chang, Yuan-Ching; Yang, Youngsen; Vladimirov, Vladimir; Jain, Minish; Tsang, Janice; Pemberton, Karine; Sadrolhefazi, Behbood; Jin, Xidong; Tseng, Ling-Ming | Breast cancer research and treatment | 6 | 5 | |
2016 | Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): An open-label, randomised, phase 3 trial | Harbeck N.; CHIUN-SHENG HUANG ; Hurvitz S.; Yeh D.-C.; Shao Z.; Im S.-A.; Jung K.H.; Shen K.; Ro J.; Jassem J.; Zhang Q.; Im Y.-H.; Wojtukiewicz M.; Sun Q.; Chen S.-C.; Goeldner R.-G.; Uttenreuther-Fischer M.; Xu B.; Piccart-Gebhart M.; Krasnozhon D.; Tong Z.; Arora R.S.; Jacob L.A.; Staroslawska E.; Wang X.; Satya Suresh Attili V.; Mehta A.O.; Lee S.H.; Tseng M.-L.; Perera N.A.M.; Huizing M.; Melichar B.; Grigiene R.; Bharwani L.; Cortes J.; Garcia M.; Chirgwin J.; Baranau Y.; Ermakov N.; Li W.; Lin T.; Qin S.; Shen P.; Yang J.; Dohollou N.; Kerbrat P.; Uleer C.; Kristeleit H.; Nagarkar R.V.; Crown J.; Kelly C.; Kaufman B.; Ionta M.T.; Park K.H.; Farhat F.; Chin L.S.; Sufliarsky J.; Saenz J.A.G.; Begbie S.; Dittrich C.; Karchmit Y.; Awada A.; Bines J.; Rigo R.; Califaretti N.; Sridhar S.; Villa D.; Jiang Z.; Wang X.; Wu G.; Shu W.; Zheng H.; Delva R.; Pivot X.; Beckmann M.; Bischoff J.; Gerber B.; Maass N.; Richters L.; Schumacher C.; Jain M.M.; Indelli M.; Purkalne G.; Juozaityte E.; Erdkamp F.L.G.; Sanchez F.S.; Susko-Kazamowicz M.; Sousa S.; Mukhametshina G.; Shomova M.; Yap Y.S.; Beniak J.; Grasic C.; Demetriou G.; Maart K.; Pienaar R.; Rapoport B.; Chacon J.I.; Cao M.G.; Chen S.-T.; Chang H.-T.; Kaplan E.; Lawler W.; Carraro S.; Lerzo G.; Chan A.; Snyder R.; Noryk D.; Graas M.-P.; Aleixo S.; Caleffi M.; Franke F.; Hegg R.; Santi P.X.; Vinholes J.; Zereu M.; Ghedira S.; Poirier E.; Yelle L.; Yanez E.; Liu J.; Luo R.; Pecha V.; Petruzelka L.; Azim H.A.; Shamaa S.S.; Brain E.; Chauffert B.; Espie M.; Lortholary A.; Petit T.; Augustin D.; Barinoff J.; Fett W.; Hannig C.V.; Kurbacher C.M.; Otremba B.; Paepke S.; Adamson D.; Kristeleit H.; O'brien M.; Bhattacharyya G.S.; Krishnan S.; Mohan R.; Nag S.; Fried G.; Isacson R.; Nakayama T.; Kudaba I.; Luna G.A.; Dercksen M.W.; Honkoop A.; Tjan-Heijnen V.C.G.; van den Bosch J.; Palominos O.M.; Blasinska-Morawiec M.; Szczylik C.; Wysocki P.; Damasceno M.; Pais A.; Biakhov M.; Chovanec J.; Harris J.; Caranana V.; Lopez R.; Tusquets I.; Chang T.-W.; Liu M.-C.; Altundag K.; Gokmen E.; Avery T.; Chan D.; Kendall S.; Hetzel D.; Kass F.; Singh J.; The LUX-Breast 1 study group | The Lancet Oncology | 105 | 91 | |
1997 | Ages at different reproductive events, numbers of menstrual cycles in between and breast cancer risk | WEI-CHU CHIE ; Fu C.-M.; WEN-CHUNG LEE ; Li C.-Y.; CHIUN-SHENG HUANG ; KING-JEN CHANG ; Lin R.-S. | Oncology Reports | 5 | 0 | |
1998 | Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset) | Lo Y.-L.; Yu J.-C.; CHIUN-SHENG HUANG ; Tseng S.-L.; Chang T.-M.; KING-JEN CHANG ; Wu C.-W.; Shen C.-Y. | International Journal of Cancer | 44 | | |
2009 | Analysis of Elastographic and B-mode Features at Sonoelastography for Breast Tumor Classification | Moon W.K.; CHIUN-SHENG HUANG ; Shen W.-C.; Takada E.; Chang R.-F.; Joe J.; Nakajima M.; Kobayashi M. | Ultrasound in Medicine and Biology | 62 | 47 | |
2004 | Angiogenic response of locally advanced breast cancer to neoadjuvant chemotherapy evaluated with parametric histogram from dynamic contrast-enhanced MRI | YEUN-CHUNG CHANG ; CHIUN-SHENG HUANG ; Liu Y.-J.; Chen J.-H.; YEN-SHEN LU ; WEN-YIH TSENG | Physics in Medicine and Biology | 71 | 63 | |
2021 | Artificial Intelligence Aids Cardiac Image Quality Assessment for Improving Precision in Strain Measurements | KUAN-CHIH HUANG ; CHIUN-SHENG HUANG ; MAO-YUAN SU ; Hung, Chung-Lieh; Ethan Tu, Yi-Chin; Lin, Lung-Chun ; HWANG, JUEY-JEN | JACC. Cardiovascular imaging | 18 | 13 | |
2023 | ASO Visual Abstract: A Novel Injection Protocol Using Voluven®-Assisted Indocyanine Green with Improved Near-Infrared Fluorescence Guidance in Breast Cancer Sentinel Lymph Node Mapping: A Translational Study | Hsieh, Yung Chun; Guo, Kai Wei; Wang, Man Wen; Su, Shih Po; Syu, Yu Han; CHIUN-SHENG HUANG ; Chan, Yang Hsiang | Annals of surgical oncology | | | |
1999 | Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence | CHIUN-SHENG HUANG ; Chern H.-D.; Shen C.-Y.; Hsu S.-M.; KING-JEN CHANG | International Journal of Cancer | 59 | | |
2017 | Association between radiosensitivity and molecular subtypes in patients with early-stage breast cancer and lymph node-negative status | SUNG-HSIN KUO ; CHIUN-SHENG HUANG | Translational Cancer Research | 4 | 4 | |
2020 | Automated whole breast segmentation for hand-held ultrasound with position information: Application to breast density estimation | Chang, J.-F.; CHIUN-SHENG HUANG ; RUEY-FENG CHANG | Computer Methods and Programs in Biomedicine | 2 | 2 | |